CIK 0001802768 · Large accelerated filer
Royalty Pharma plc
Sign in to watch- Ticker
- RPRX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- United Kingdom
- Entity type
- operating
- Phone
- (212) 883-0200
- Business address
- 110 EAST 59TH STREET, NEW YORK, NY, 10022
- 4 Planned sale EVP & CFO sold 34,791 shares at $45.32 ($1,576,606)
- 4 Grant or award CEO, Chairman of the Board acquired 157,828 shares (grant or award)
- 4 Grant or award EVP & CFO acquired 26,626 shares (grant or award)
- 4 Grant or award EVP & Vice Chairman acquired 26,626 shares (grant or award)
- 4 Grant or award EVP, Research & Investments acquired 19,970 shares (grant or award)
- 4 Planned sale EVP & CFO sold 243,541 shares at an average $42.54 ($10,360,814)
- 4 Planned sale EVP, Research & Investments sold 20,000 shares at $41.09 ($821,810)
- 4 Planned sale EVP, Research & Investments sold 20,000 shares at $40.26 ($805,110)
- 4 Planned sale EVP & CFO sold 69,582 shares at $39.35 ($2,737,940)
- 4 Planned sale EVP, Research & Investments sold 20,000 shares at $39.52 ($790,346)
- 4 Planned sale EVP, Research & Investments sold 20,000 shares at $40.78 ($815,634)
- 3 Insider Initial Statement of Ownership
- 4 Planned sale EVP & CFO sold 69,582 shares at $38.42 ($2,673,041)
- 4 Planned sale EVP, Research & Investments sold 20,000 shares at $38.48 ($769,650)
- 4 Grant or award Director acquired 967 shares (grant or award)
- 4 Planned sale EVP, Research & Investments sold 20,000 shares at $39.32 ($786,380)
- 4 Planned sale EVP, Research & Investments sold 20,000 shares at $38.38 ($767,582)
- 4 Planned sale EVP, Investments & CLO sold 110,000 shares at an average $38.55 ($4,240,333)
- 4 Planned sale EVP, Research & Investments sold 20,000 shares at $38.32 ($766,420)
- 4 Planned sale EVP & CFO sold 69,582 shares at $38.36 ($2,669,172)
Page 3 of 18 · 342 filings